Related Experiment Video
Updated: Jul 19, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Female sexual dysfunction in essential hypertension: a common problem being uncovered
Michael Doumas1, Sotirios Tsiodras, Alexandros Tsakiris
1Hypertension Outpatient Clinic, 4th Department of Internal Medicine, University of Athens, Attikon Hospital, Greece. michalisdoumas@yahoo.co.uk
Journal of Hypertension
|November 4, 2006
Summary
Female sexual dysfunction (FSD) is more common in women with high blood pressure. Effective blood pressure control can reduce FSD prevalence, improving quality of life for hypertensive women.
Area of Science:
- Cardiology
- Urology
- Gynecology
Background:
- Female sexual dysfunction (FSD) is a growing area of scientific and public interest.
- FSD remains under-investigated in patients with essential hypertension.
- Hypertension management needs to consider its impact on female sexual health.
Purpose of the Study:
- To evaluate the prevalence of sexual dysfunction in women with essential hypertension.
- To compare FSD rates between hypertensive and normotensive women.
- To analyze the influence of age, hypertension severity, duration, and treatment on FSD.
Main Methods:
- The study included 417 sexually active women from an outpatient hypertension clinic.
- Female Sexual Function Index (FSFI) questionnaire assessed FSD.
- Univariate and multivariate analyses identified predictors of FSD.
Main Results:
- Sexual dysfunction was found in 42.1% of hypertensive women versus 19.4% in normotensive women (OR, 3.2).
- Higher systolic blood pressure (r = -0.67) and beta-blocker use were significant predictors of FSD.
- Adequate hypertension control correlated with a lower prevalence of FSD.
Conclusions:
- FSD is significantly more prevalent in women with essential hypertension.
- Effective blood pressure control is associated with a decline in FSD prevalence.
- Managing FSD is crucial for enhancing the quality of life in hypertensive women.
Related Concept Videos
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:28Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...